TRENDS IN RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING KIDNEY TRANSPLANTION

DOI: https://doi.org/10.29296/25877305-2018-01-11
Download full text PDF
Issue: 
1
Year: 
2018

S. Martirosyan; E. Kosmacheva, MD Scientific Research Institute – S.V. Ochapovsky Regional Clinical Hospital №1 of Krasnodar

Structural and functional changes in the cardiovascular system, lipid spectrum and indicators were investigated to determine risk factors for complications in kidney recipients in different periods after transplantation.

Keywords: 
nephrology
transplantation
renal allograft
cardiovascular risk
dyslipidemia
hypertension



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Tomilina N.A., Volgina G.V., Bikbov B.T. i dr. Problema serdechno-sosudistyh zabolevanij pri hronicheskoj pochechnoj nedostatochnosti // Nefrologija i dializ. – 2003; 5 (1): 15–21.
  2. Ojo A., Nanson J., Wolfe R. Long-term survival in renal transplant recipients with graft function // Kidney Int. – 2000; 57: 307–13.
  3. Rtischev O.V. Struktura prichin letal'nyh ishodov u bol'nyh, nahodivshihsja na programmnom gemodialize // Klin. nefrologija. – 2011; 1: 43–6.
  4. Levey A., Eknoyan G. Cardiovascular disease in chronic renal disease// Nephrol. Dial. Transplant. – 1999; 14: 828–33.
  5. Prasad R., Ruzicka M., Burns K. et al. Hypertension in dialysis and kidney transplant patients // Can. J. Cardiol. – 2009; 25 (5): 309–14.
  6. McCullough P., Chan C., Weinhandl E. et al. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease // Am. J. Kidney Dis. – 2016; 68 (5S1): 5–14.
  7. Rigatto C., Parfrey P., Foley R. et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease // J. Am. Soc. Nephrol. – 2002; 13: 1084–90.
  8. Hager M., Narla A., Tannock L. Dyslipidemia in patients with chronic kidney disease // Rev. Endocr. Metab. Disord. – 2017; 18 (1): 29–40.